Pasithea Therapeutics Corp.

KTTAWSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1841330

Concept	FY2024	FY2023	FY2022	FY2021
Revenues	—	—	$15.1K	$15.1K
Cost of Goods and Services Sold	—	—	$17.3K	$17.3K
Gross Profit	—	—	—	-$2.2K
Research and Development Expense	$8.1M	$2.7M	$2.7M	—
Selling, General and Administrative Expense	$7.9M	$9.9M	$4.5M	$41.0K
Operating Income (Loss)	-$16.0M	-$12.6M	-$4.5M	-$41.0K
Interest Expense	—	—	$508.00	—
Nonoperating Income (Expense)	$471.6K	—	—	$2.3M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$15.5M	-$11.7M	-$2.2M

Concept	FY2024	FY2023	FY2022	FY2021
Assets	$26.1M	$45.2M	$53.3M	$248.0K
Assets, Current	$16.7M	$34.1M	$53.3M	$248.0K
Cash and Cash Equivalents, at Carrying Value	$16.3M	$33.1M	$53.0M	$243.7K
Liabilities	$2.7M	$2.7M	$1.9M	$6.6K
Liabilities, Current	$2.6M	$1.9M	$447.3K	$6.6K
Stockholders' Equity Attributable to Parent	$42.5M	$51.4M	$241.4K	$241.4K
Common Stock, Shares, Outstanding	$1.0M	$1.3M	$23.0M	$7.5M

Concept	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	—	—	-$3.2M	-$38.7K
Net Cash Provided by (Used in) Investing Activities	—	—	-$21.5K	-$21.5K
Net Cash Provided by (Used in) Financing Activities	—	—	$55.9M	$282.3K
Payments to Acquire Property, Plant, and Equipment	$34.3K	$107.1K	$21.5K	$21.5K
Payments for Repurchase of Common Stock	$3.7M	$3.7M	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)